GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.0830
+0.0014 (1.72%)
Aug 3, 2026, 2:00 PM CET
GenSight Biologics Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.65 | 2.63 | 2.96 | 4.87 | 7.71 | |
Revenue Growth | -75.16% | -11.41% | -39.10% | -36.89% | 3.62% |
Gross Profit | 0.65 | 2.63 | 2.96 | 4.87 | 7.71 |
Selling, General & Admin | 5.27 | 6.07 | 13.3 | 13.36 | 12.92 |
Research & Development | 6.44 | 12.37 | 19.36 | 19.34 | 22.92 |
Other Operating Expenses | 11.71 | 18.44 | 32.66 | 32.7 | 35.84 |
Total Operating Expenses | 23.41 | 36.88 | 65.32 | 65.4 | 71.67 |
Operating Income | -11.05 | -15.81 | -29.7 | -27.84 | -28.13 |
Interest Income | -0.99 | 1.83 | 3.48 | 3.89 | 2.01 |
Interest Expense | - | - | - | 3.67 | -2.5 |
Total Non-Operating Income (Expense) | -0.99 | 1.83 | 3.48 | 7.56 | -0.49 |
Pretax Income | -12.04 | -13.98 | -26.22 | -20.27 | -28.62 |
Provision for Income Taxes | - | - | 0 | -0.01 | -0 |
Net Income | -12.04 | -13.98 | -26.22 | -20.27 | -28.61 |
Net Income to Common | -12.04 | -14 | -26.22 | -27.63 | -28.62 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 148 | 96 | 48 | 46 | 45 |
Shares Outstanding (Diluted) | 148 | 96 | 48 | 46 | 45 |
Shares Change | 54.91% | 98.18% | 4.29% | 2.61% | 28.54% |
EPS (Basic) | -0.08 | -0.15 | -0.54 | -0.60 | -0.63 |
EPS (Diluted) | -0.08 | -0.15 | -0.54 | -0.60 | -0.63 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -9.17 | -12.94 | -24.67 | -34.01 | -17.17 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.06 | -0.14 | -0.51 | -0.73 | -0.38 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -1695.40% | -602.40% | -1002.23% | -572.15% | -364.85% |
Profit Margin | -1846.78% | -532.57% | -884.95% | -416.57% | -371.16% |
FCF Margin | -1407.06% | -492.88% | -832.70% | -698.97% | -222.74% |
EBITDA | -10.59 | -14.75 | -27.52 | -26.77 | -27.2 |
EBITDA Margin | -1624.08% | -562.06% | -928.69% | -550.34% | -352.81% |
EBIT | -11.05 | -15.81 | -29.7 | -27.84 | -28.13 |
EBIT Margin | -1695.40% | -602.40% | -1002.23% | -572.15% | -364.85% |
Effective Tax Rate | 0.00% | 0.00% | 0.00% | 0.02% | 0.01% |